Relaxin as an independent risk factor predicting mortality

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/74 (2006.01)

Patent

CA 2527200

Disclosed are methods of characterising life expectancy of human individuals on the basis of measured relaxin levels. In one aspect of the invention the human individuals are end-stage-kidney-disease patients.

L'invention concerne des méthodes permettant de caractériser l'évaluation de durée de vie d'individus humains sur la base des mesures des niveaux de relaxine. Dans un aspect de l'invention, ces individus humains sont des patients atteints de maladie rénale au stade terminal.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Relaxin as an independent risk factor predicting mortality does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Relaxin as an independent risk factor predicting mortality, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Relaxin as an independent risk factor predicting mortality will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1700914

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.